MACC1 and gastric cancer: Furthermore, TGF-β1 inhibitor disitertide and TGFβR-I inhibitor LY-364947 abrogated the MACC1-AS1 expression in GC cells treated with MSC-CM of >3-kD fraction (Fig. 3m, n).